Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Gottex assets down 2.1% ($7.41bn) in Q2, flagship funds of hedge funds post positive returns YTD

Friday, July 20, 2012

Benedicte Gravrand, Opalesque Geneva: In today’s trading statement for the second quarter of 2012, Gottex Fund Management Holdings Ltd, an independent global fund of funds group incorporated in Guernsey and listed in Switzerland, revealed that its flagship fund of hedge fund products continue to outperform their benchmark and post positive returns YTD. This was due to "exceptional performance" by alternative credit strategies (up 5.9% YTD), and equity portable alpha strategies (up 11.2% YTD).

Gottex’s core market neutral strategies were up around 2% YTD and have continued to outperform their benchmark as they did in 2011, according to the statement. Gottex expects its core flagship market neutral plus product (1.1% away from its high water mark at the end of June) to start accruing performance fees in H2. Meanwhile, the firm’s second largest market neutral product was 6% away from regaining its high water mark.

Total fee-earning assets for the group decreased by 2.1% to $7.41bn, compared to $7.57bn at the end of March, primarily as a result of $140m negative impact from technical factors and foreign exchange, partly due to depreciation of the Euro. This total consisted of $5.67bn in AuM (compared to $ 5.71bn at 31 March 2012), and LUMA GSS assets of $1.74bn (managed account platform and outsourced middle office services subsidiary).

This is not taking into account the pending acquisition of Hong Kong based Penjing Asset Management (......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its